Similarly, no differences regarding mean age of patients with lower levels of MBL (<500 ng/mL) (n=13) versus higher levels of MBL (>500 ng/mL) (n=44) were found when the group of patients with other pituitary diseases (n=57) was considered (48.38 ± 4.11 vs. 44.61 ± 2.60, p=0.479). The gene discussed is MBL2; the disease is pituitary gland disorder.